Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Ischaemia versus bleeding: the art of clinical decision-making.

Stone GW.

Lancet. 2009 Feb 28;373(9665):695-6. doi: 10.1016/S0140-6736(09)60413-X. No abstract available.

PMID:
19249613
2.

Predictors of bleeding in acute coronary syndromes with clopidogrel and prasugrel.

Rodriguez L, Conde D, Lalor N, Elissamburu P, Trivi M.

Am J Emerg Med. 2013 Aug;31(8):1287. doi: 10.1016/j.ajem.2013.05.025. No abstract available.

PMID:
23769852
3.

[Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].

Silber S, Helms TM, Garlichs C, Arntz HR, Weil J, Ince H, Klingenheben T, Hoffmann S, Boudriot E, Steiger H, Zugck C.

Dtsch Med Wochenschr. 2011 Apr;136(15):782-5. doi: 10.1055/s-0031-1272567. Review. German. No abstract available.

PMID:
21432747
4.

[Prasugrel or clopidogrel in patients with coronary intervention].

Schrör K.

Internist (Berl). 2009 Nov;50(11):1293-6. doi: 10.1007/s00108-009-2519-3. German. No abstract available.

PMID:
19830398
5.

Will prasugrel supersede clopidogrel for acute coronary syndromes?

Hankey GJ, Eikelboom JW, Langton PE.

Med J Aust. 2008 Apr 7;188(7):381-2. Review. No abstract available.

PMID:
18393737
6.

Clopidogrel versus prasugrel: times are changing, but not for everyone.

Dobesh PP.

Pharmacotherapy. 2009 Dec;29(12):1393-6. doi: 10.1592/phco.29.12.1393. No abstract available.

PMID:
19947798
7.

[Prodrug activation as a crucial difference. Prasugrel - a new ADP receptor antagonist].

Alban S.

Pharm Unserer Zeit. 2009;38(4):320-8. doi: 10.1002/pauz.200900321. Review. German. No abstract available.

PMID:
19572350
8.

Future of oral antiplatelet therapy: four challenged hypotheses.

Serebruany VL, Makarov LM.

Thromb Haemost. 2009 Jun;101(6):1041-3. No abstract available.

PMID:
19492145
9.

Prasugrel for acute coronary syndromes: faster, more potent, but higher bleeding risk.

Lazar LD, Lincoff AM.

Cleve Clin J Med. 2009 Dec;76(12):707-14. doi: 10.3949/ccjm.76a.09116.

10.

Prasugrel offers consistent platelet control in appropriate patients requiring treatment.

Aalbers J.

Cardiovasc J Afr. 2011 Mar-Apr;22(2):107, 109. No abstract available.

11.

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.

Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, Antman EM; TRITON-TIMI 38 investigators..

Lancet. 2009 Feb 28;373(9665):723-31. doi: 10.1016/S0140-6736(09)60441-4.

PMID:
19249633
12.

For better or for worse: the future of antiplatelet therapy.

Alvarez W Jr.

Am J Health Syst Pharm. 2008 Jun 1;65(11):1017. doi: 10.2146/ajhp080115. No abstract available.

PMID:
18499873
13.

Meta-Analysis of Randomized Controlled Trials Comparing Risk of Major Adverse Cardiac Events and Bleeding in Patients With Prasugrel Versus Clopidogrel.

Chen HB, Zhang XL, Liang HB, Liu XW, Zhang XY, Huang BY, Xiu J.

Am J Cardiol. 2015 Aug 1;116(3):384-92. doi: 10.1016/j.amjcard.2015.04.054. Review.

PMID:
26051379
14.

Prasugrel (Effient) vs. clopidogrel (Plavix).

[No authors listed]

Med Lett Drugs Ther. 2009 Sep 7;51(1320):69-70. Review.

PMID:
19738549
15.
16.

Predictors of myocardial infarction after an acute coronary syndrome with clopidogrel and prasugrel.

Lalor N, Conde D, Rodriguez L, Elissamburu P, Trivi M.

Am J Emerg Med. 2013 Aug;31(8):1287-8. doi: 10.1016/j.ajem.2013.05.037. No abstract available.

PMID:
23806726
17.

Management of a hypersensitivity reaction to thienopyridines: prasugrel-induced fever and hepatitis resolved after switching to clopidogrel.

Fernández-Ruiz M, Carbonell-Porras A, García-Reyne A, López-Medrano F.

Rev Esp Cardiol (Engl Ed). 2012 Aug;65(8):773-4. English, Spanish. No abstract available.

PMID:
22377199
18.

Prasugrel: Clinical development and therapeutic application.

Guerra DR, Tcheng JE.

Adv Ther. 2009 Nov;26(11):999-1011. doi: 10.1007/s12325-009-0081-y. Review.

PMID:
20020231
19.

[Platelet inhibition with prasugrel].

Gassanov N, Caglayan E, Nia AM, Erdmann E, Er F.

Dtsch Med Wochenschr. 2010 Aug;135(31-32):1542-6. doi: 10.1055/s-0030-1262444. Review. German.

PMID:
20665417
20.

New antiplatelet agents in the treatment of acute coronary syndromes.

Sabouret P, Taiel-Sartral M.

Arch Cardiovasc Dis. 2014 Mar;107(3):178-87. doi: 10.1016/j.acvd.2014.01.009. Review.

Supplemental Content

Support Center